In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
ID: NIH_NIDA75N95025XXXXType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Diagnostic Imaging Centers (621512)

PSC

IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY (6525)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking innovative proposals for the development of In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems. The initiative aims to address the challenges posed by light scattering in biological tissues, which currently limits the effectiveness of non-invasive optical imaging techniques in assessing tissue function and structure. This funding opportunity encourages the advancement of next-generation imaging technologies that can achieve deeper penetration and higher resolution in biological systems. Interested applicants should note that the application due date is March 7, 2025, by 5:00 PM local time, and are encouraged to submit a letter of intent by the same date. For further inquiries, contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Pathology Support for the National Institute of Environmental Health Sciences
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for pathology support services for the National Institute of Environmental Health Sciences (NIEHS) under solicitation number 75N96025R00003. The procurement aims to secure comprehensive pathology-related services, including technical support, histopathological evaluations, and assistance with reporting and publication of findings, with a contract period anticipated from July 2025 to July 2026, and options for extensions up to July 2035. This initiative is crucial for enhancing NIEHS's research capabilities while ensuring compliance with federal regulations regarding human subjects and promoting inclusivity in research practices. Interested parties must submit their proposals by 4:00 PM EST on January 6, 2025, and can direct inquiries to Sue McKenzie at sue.mckenzie@nih.gov or Erica Kitzmiller at erica.kitzmiller@nih.gov.
    NIDDK Scientist
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), is seeking to procure the services of a specialized scientist through a non-competitive contract with Optimal Systems, LLC. The objective of this procurement is to leverage the contractor's expertise in biomedical imaging and medical image analysis to develop a non-invasive, cost-effective alternative to liver biopsy for assessing liver inflammation, a critical need for millions affected by liver disease. The contractor will implement a 3D Magnetic Resonance Elastography (MRE) technique, develop algorithms for liver tissue analysis, and utilize machine learning to evaluate inflammation levels, with deliverables including weekly status meetings and contributions to scientific publications. The anticipated contract period is from February 2, 2025, to February 1, 2026, with payment terms set to monthly in arrears. Interested parties may express their interest, but the decision on whether to pursue a competitive process lies solely with the government. For further inquiries, contact Ijada C. Fields at ijada.fields@nih.gov or 301-435-5452.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative. This program aims to develop innovative solutions for the diagnosis and treatment of ocular conditions, particularly focusing on dry eye disease (DED) through advanced biomarker analysis and therapeutic delivery systems. The initiative emphasizes the creation of a continuous monitoring biosensor integrated into a therapeutic device, leveraging artificial intelligence for non-invasive treatment methods, and encourages collaboration among commercial entities and academic institutions. Interested parties should contact the OCULAB Team at OCULAB@ARPA-H.gov for further details, with multiple awards anticipated as part of this funding opportunity, which is set to culminate with the final OCULAB Innovative Solutions Opening (ISO) on December 20, 2024.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.
    Opera Phenix Plus High-Content Screening System (or equal)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an Opera Phenix Plus High-Content Screening System or an equivalent product for the Intramural Center for Alzheimer’s and Related Dementias (CARD). The procurement aims to acquire a high-content imaging system capable of analyzing cellular samples, including organoids and tissue slices, to support research on neurodegenerative diseases. This initiative is critical for advancing the understanding of Alzheimer’s disease and related conditions through the analysis of induced pluripotent stem cells (iPSCs). Interested vendors must submit their capability statements by December 27, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring compliance with the specified requirements and guidelines.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.
    R--Technical development of cardiovascular MRI
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the technical development of cardiovascular MRI technology. This opportunity aims to enhance the capabilities and applications of cardiovascular magnetic resonance imaging, which is crucial for advancing diagnostic and therapeutic strategies in cardiovascular health. Interested parties should note that the presolicitation notice is categorized under NAICS code 541990, indicating a focus on professional, scientific, and technical services. For further inquiries, potential bidders can contact Moses Amawudah at moses.amawudah@nih.gov.
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry methods to enhance triage and treatment during radiation emergencies, with each proposal focusing on one of these goals. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to improve the response to radiation exposure and associated health risks. Proposals are due by March 19, 2025, and interested parties must register in the System for Award Management (SAM); the estimated cost and fixed fee for the contract are to be determined. For further inquiries, contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Research Opportunity Announcement (ROA): All of Us Biobank
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is soliciting proposals through a Research Opportunity Announcement (ROA) for the All of Us Biobank, aimed at enhancing the collection, processing, and distribution of high-quality biospecimens from a diverse participant pool to support biomedical research. The initiative seeks to fund one award that will maintain existing biobank specimens and expand operations to support the collection and dissemination of diverse biospecimens, with a focus on innovative technologies and methods. This program is critical for advancing health research and improving health equity by collecting data from historically underrepresented groups, with anticipated funding ranging from $13 million to $50 million over a potential five-year period. Interested proposers must submit a Letter of Intent by December 9, 2024, and can direct inquiries to AllofUsDCDAwardRequirements@nih.gov.